These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 11296693)

  • 21. Nonalcoholic Fatty liver disease and obesity.
    Saadeh S
    Nutr Clin Pract; 2007 Feb; 22(1):1-10. PubMed ID: 17242448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harrison SA; Neuschwander-Tetri BA
    Clin Liver Dis; 2004 Nov; 8(4):861-79, ix. PubMed ID: 15464659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
    Belfort R; Harrison SA; Brown K; Darland C; Finch J; Hardies J; Balas B; Gastaldelli A; Tio F; Pulcini J; Berria R; Ma JZ; Dwivedi S; Havranek R; Fincke C; DeFronzo R; Bannayan GA; Schenker S; Cusi K
    N Engl J Med; 2006 Nov; 355(22):2297-307. PubMed ID: 17135584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease: is all the fat bad?
    Clouston AD; Powell EE
    Intern Med J; 2004 Apr; 34(4):187-91. PubMed ID: 15086699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
    Powell EE; Cooksley WG; Hanson R; Searle J; Halliday JW; Powell LW
    Hepatology; 1990 Jan; 11(1):74-80. PubMed ID: 2295475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease.
    Younossi ZM
    Curr Gastroenterol Rep; 1999; 1(1):57-62. PubMed ID: 10980928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty liver and nonalcoholic steatohepatitis.
    Neuschwander-Tetri BA
    Clin Cornerstone; 2001; 3(6):47-57. PubMed ID: 11501194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease: a clinical review.
    Sass DA; Chang P; Chopra KB
    Dig Dis Sci; 2005 Jan; 50(1):171-80. PubMed ID: 15712657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W; McCullough AJ
    Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?
    Afdhal NH
    JAMA; 2012 Aug; 308(6):608-16. PubMed ID: 22760235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steatohepatitis in obese individuals.
    Youssef WI; McCullough AJ
    Best Pract Res Clin Gastroenterol; 2002 Oct; 16(5):733-47. PubMed ID: 12406442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
    Mehta K; Van Thiel DH; Shah N; Mobarhan S
    Nutr Rev; 2002 Sep; 60(9):289-93. PubMed ID: 12296456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis.
    Bril F; Lomonaco R; Orsak B; Ortiz-Lopez C; Webb A; Tio F; Hecht J; Cusi K
    Hepatology; 2014 Jun; 59(6):2178-87. PubMed ID: 24777953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.